Covidence: Why Structured Data Extraction Is Becoming the New Power Lever in Evidence & Regulatory Strategy

Overview: How Covidence’s AI‑Driven Structured Data Extraction & Evidence Intelligence Platform Transforms Evidence & Regulatory Strategy

Covidence is an evidence synthesis workflow platform that supports Structured Data Extraction & Evidence Intelligence by helping teams transform large volumes of study reports into organised, analysis‑ready datasets. It addresses the bottleneck of manual, error‑prone steps in systematic reviews and related evidence projects, where teams must sift through thousands of records, extract comparable data fields, and maintain clear links back to primary sources. Covidence incorporates machine learning features such as the Cochrane RCT classifier, automated removal of non‑RCTs, and relevance sorting, which use trained models and active learning to prioritise likely‑eligible studies and reduce the screening and extraction burden before structured data are captured.

Within this category, Covidence acts as a central hub where imported references can be deduplicated, screened, and passed into configurable extraction templates that capture population, intervention, comparator, outcome, and risk‑of‑bias information in a structured format. These structured datasets can be exported into statistical packages or guideline tools, supporting downstream meta‑analysis and decision frameworks without re‑keying data. In practice, the combination of ML‑assisted prioritisation, standardised workflows, and team collaboration features can shorten review timelines by up to a third, while improving consistency of extracted variables across reviewers and projects.

Last checked on May 19, 2026: Covidence remains an active, Cochrane-backed evidence synthesis platform, with recent enhancements to AI screening automation, relevance sorting, and flexible data extraction forms aligned with formal responsible-AI principles.

What is Covidence?

Covidence is a web-based evidence synthesis platform that streamlines structured data extraction from clinical and scientific studies for systematic reviews, scoping reviews, and related evidence projects. It is primarily used by researchers and evidence synthesis teams who need to screen large literature sets, extract comparable PICO and outcome data into standardised templates, and export analysis-ready datasets for meta-analysis and guideline development. Covidence is differentiated by its end-to-end systematic review workflow, configurable Extraction 1 and Extraction 2 modules for different review types, and integrated machine learning features (such as relevance prioritisation and RCT classifiers) that reduce manual workload while maintaining traceability back to primary studies.

Why Do Leading Healthcare Teams Trust Covidence?

• Covidence has a long-standing strategic relationship with Cochrane, which recommends Covidence for new reviews, anchoring the platform in established evidence synthesis methodology.

• The platform is widely adopted by major academic medical centers and health organisations (e.g., Mayo Clinic and multiple university health systems), which host institutional guides and subscriptions for Covidence-based evidence syntheses.

• Covidence won the 2022 Australian Impact Investment Award in the Impact Enterprise category, recognising its role in enabling evidence to inform national guidelines and policy decisions in areas such as stroke, maternal health, and COVID‑19.

• Case examples cited by Covidence include contributions to national guideline updates and policy decisions in Australia and Indonesia, providing real-world evidence of its use in high-stakes clinical and public health decision-making.

• Covidence is positioned as a cloud-based platform for systematic and scoping reviews, with institutional libraries and evidence services describing it as a “gold standard” workflow for high-quality evidence syntheses, which supports its credibility for regulatory- and guideline-facing work.

• The product incorporates machine learning components such as the Cochrane RCT classifier and relevance prioritisation, developed and documented within the evidence synthesis community, which allows users to understand and evaluate how AI is applied in screening and selection.

• Library guides and institutional documentation describe Covidence as enabling transparent workflows with audit trails from screening through data extraction and quality assessment, which is important for reproducibility and defensibility of evidence used in regulatory or guideline processes.

• There is no public indication of mergers, acquisitions, or major corporate disruptions; Covidence appears to be a stable, mission-focused organisation that has operated in the evidence synthesis space for multiple years